JAK-STAT1 as Therapeutic Target for EGFR Deficiency-Associated Inflammation and Scarring Alopecia

    November 2024 in “ EMBO Molecular Medicine ”
    Karoline Strobl, Jörg Klufa, Regina Jin … Thomas Bauer
    Studysummary In this study, researchers found that disrupting EGFR signaling in mice led to increased inflammation and hair follicle damage but that inhibiting the JAK-STAT1 pathway could restore hair growth and skin function.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on embopress.org →
    Discuss this study in the Community →

    Research cited in this study 22

    1. Topical Tofacitinib for Patients with Lichen Planopilaris and/or Frontal Fibrosing Alopecia Journal of the American Academy of Dermatology · 2024
    2. Regulatory T Cells in Skin Mediate Immune Privilege of the Hair Follicle Stem Cell Niche Science Immunology · 2024
    3. EGFR Inhibitor-Induced Folliculitis Decalvans: A Case Series and Management Guidelines Anti-Cancer Drugs · 2023
    4. Developmentally Programmed Early-Age Skin Localization of iNKT Cells Supports Local Tissue Development and Homeostasis Nature Immunology · 2023
    5. Primary Cicatricial Alopecias Are Characterized by Dysregulation of Shared Gene Expression Pathways PNAS Nexus · 2022
    6. Folliculitis Decalvans Responsive to Tofacitinib: A Case Series Dermatologic Therapy · 2020
    7. Hair Eruption Initiates and Commensal Skin Microbiota Aggravate Adverse Events of Anti-EGFR Therapy Science Translational Medicine · 2019
    8. IL-36γ Drives Skin Toxicity Induced by EGFR/MEK Inhibition and Commensal Cutibacterium Acnes ˜The œJournal of clinical investigation/˜The œjournal of clinical investigation · 2019
    9. EGFR Controls Hair Shaft Differentiation in a p53-Independent Manner iScience · 2019
    10. The Role of the Microbiome in Scalp Hair Follicle Biology and Disease Experimental Dermatology · 2019
    11. A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth Cell Stem Cell · 2019
    12. Genome-Wide Association Study in Frontal Fibrosing Alopecia Identifies Four Susceptibility Loci Including HLA-B*07:02 Nature Communications · 2019
    13. Tofacitinib for the Treatment of Lichen Planopilaris: A Case Series Dermatologic therapy · 2018
    14. Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases Trends in Molecular Medicine · 2018
    15. Quiescent Tissue Stem Cells Evade Immune Surveillance Immunity · 2018
    16. Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management ˜The œjournal of investigative dermatology. Symposium proceedings/˜The œJournal of investigative dermatology symposium proceedings · 2017
    17. Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata JCI insight · 2016
    18. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014
    19. Lichen Planopilaris Is Characterized By Immune Privilege Collapse Of The Hair Follicle's Epithelial Stem Cell Niche The Journal of Pathology · 2013
    20. A Case of Cicatricial Alopecia Associated with Erlotinib Annals of Dermatology · 2011
    21. Epidermal Stem Cell Diversity and Quiescence EMBO molecular medicine · 2009
    22. The Hair Follicle as a Dynamic Mini-Organ Current Biology · 2009